TGFβ1 has been detected in blood and urine of patients with HCC, and its presence is associated with poor prognosis.56 Our data therefore suggest that attenuated TGFβ signaling contributes to reduced HCC progression in gp130Δhepa livers after DEN injection. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.